Reply
Jamuna Karkhanis, Elizabeth C. Verna, Matthew S. Chang, R. Todd Stravitz, Michael L. Schilsky, William M. Lee, Robert S. Brown – 5 March 2014
Historical, present, and future significance of corticosteroid in the treatment of acute liver failure
Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka – 4 March 2014
Reply
Martin Lagging, Karolina Rembeck, Jesper Waldenström, Staffan Nilsson, Kristina Nyström, Anna Martner, Magnus Lindh, Gunnar Norkrans, Johan Westin, Court Pedersen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Kristine Mørch, Peer B. Christensen, Kristoffer Hellstrand – 4 March 2014
Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3
Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu – 4 March 2014
FDA bridging analyses confirmed in clinical trial
Poonam Mishra, Jeffry Florian, Jeffrey Murray – 2 March 2014
Reply
Ju Dong Yang, Ayako Suzuki – 28 February 2014
Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta
Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, Boris A. Ratsch, Kalliopi Zachou, Birgit Bremer, George N. Dalekos, Andreas Erhardt, Fehmi Tabak, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Markus Cornberg, C.‐Thomas Bock, Michael P. Manns, Heiner Wedemeyer, HIDIT‐1 Study Group – 28 February 2014 – Interferon alpha is the only treatment option for hepatitis delta virus (HDV). Trials investigating the efficacy of pegylated interferon alpha (PEG‐IFNa) showed HDV RNA negativity rates of 25‐30% 24 weeks after therapy.
A 24‐week pegylated interferon alpha‐2b versus a 12‐week pegylated interferon alpha‐2b alone or with ribavirin for patients with acute hepatitis C
Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu – 28 February 2014
Computerized physician order entry‐based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project
Blanca Sampedro, Cándido Hernández‐López, José Ramón Ferrandiz, Aitziber Illaro, Emilio Fábrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menéndez, Joaquín Cabezas, Javier Crespo – 28 February 2014 – Computerized physician order entry (CPOE) applications are widely used to prevent medical errors. In our center, a CPOE system has been in use since 2009 on both the inpatient and outpatient levels.
Reply
Mauro Bernardi, Paolo Caraceni, Roberta J. Navickis, Mahlon M. Wilkes – 28 February 2014